Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)

HNX:MKV Revenue

Cai Lay Veterinary Pharmaceutical JSC had revenue of 35.40B VND in the quarter ending June 30, 2026, with 4.65% growth. This brings the company's total for the last twelve months to 153.97B, up 25.44% year-over-year. In the year 2025, Cai Lay Veterinary Pharmaceutical JSC had annual revenue of 149.79B with 39.94% growth. That makes Cai Lay Veterinary Pharmaceutical JSC the 39,411th largest company in the world by revenue and 583rd in Vietnam.

• Revenue (ttm): 153.97B
• Revenue Growth: +25.44%
• P/S Ratio: 0.38
• Revenue / Employee: 1.37B
• Employees: 112
• Market Cap: 59.00B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	149.79B	42.75B	39.94%
Dec 31, 2024	107.04B	-3.87B	-3.49%
Dec 31, 2023	110.91B	-8.73B	-7.30%
Dec 31, 2022	119.63B	17.22B	16.82%
Dec 31, 2019	102.41B	-32.17B	-23.90%

Data Source: S&P Global Market Intelligence Last updated: Jul 18, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error